Rallybio Corporation
RLYBNASDAQHealthcare● Active
$16.22
+$0.31(+1.95%)
Market Cap$85935831
P/E Ratio—
52W High$17.574
52W Low$2.4
Rallybio Corporation (RLYB) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RLYB · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.86M | $0.64M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.09M | $0.00M | $0.15M | $0.17M | $0.11M |
| Gross Profit | $0.77M | $0.64M | ($0.15M) | ($0.17M) | ($0.11M) |
| Gross Margin %(computed) | 89.28% | 100.00% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $19.60M | $41.51M | $53.54M | $40.69M | $26.91M |
| G&A Expenses | $14.32M | $19.63M | $25.39M | $27.20M | $18.74M |
| Total Operating Expenses | $28.83M | $61.13M | $78.93M | $67.88M | $45.65M |
| Operating Income | ($28.06M) | ($60.50M) | ($78.93M) | ($67.88M) | ($45.65M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $2.19M | $4.22M | $6.15M | $1.96M | $0.05M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.01M |
| Income Before Tax | ($8.98M) | ($57.77M) | ($74.56M) | ($67.73M) | ($47.01M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | ($1.07M) | $0.00M |
| Net Income | ($8.98M) | ($57.77M) | ($74.56M) | ($66.65M) | ($47.01M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.59 | $-10.64 | $-14.72 | $-16.72 | $-11.68 |
| Wtd Avg Shares | 5.63M | 5.44M | 5.06M | 3.98M | 4.02M |
| EBITDA | ($27.97M) | ($60.37M) | ($78.78M) | ($67.72M) | ($45.39M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Rallybio Corporation data
About Rallybio Corporation (RLYB) Income Statement
Rallybio Corporation (RLYB) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, RLYB reported revenue of $0.00B, gross profit of $0.00B (gross margin 89.28%), and net income of ($0.01B) — a net profit margin of -1046.39%.
Frequently asked questions
RLYB · 4 questionsRallybio Corporation (RLYB) reported revenue of $0.00B for 2025, up 34.9% year-over-year.
RLYB revenueRLYB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09